Charcot-Marie-Tooth Disease: Clinical Trials

112 trials for Charcot-Marie-Tooth Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

50 completed, 30 recruiting, 14 unknown, 6 terminated. 42 Not applicable, 16 Phase 2, 7 Phase 1, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable42Completed 21, Recruiting 13, Unknown 4, Active not recruiting 3, Withdrawn 1
Phase 216Completed 7, Terminated 3, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 17Completed 3, Recruiting 2, Active not recruiting 1, Withdrawn 1
Phase 35Unknown 3, Completed 2

Follow Charcot-Marie-Tooth Disease: new trials by email Literature Review of Charcot-Marie-Tooth Disease trials Research Report on Charcot-Marie-Tooth Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A
scAAV1.tMCK.NTF3 - Charcot-Marie-Tooth Neuropathy Type 1A
Phase 1 / Phase 2WithdrawnNationwide Children's Hospital2027-04-012026-07-29
Muscle MRI Fat Fraction Before Surgery to Predict Strength Recovery After Foot-Drop Surgery in Charcot-Marie-Tooth Disease
Tibialis posterior tendon transfer, Individualized adjunct procedures for cavovarus deformity correction, Ankle-foot orthosis (AFO) - Foot Drop, Charcot-Marie-Tooth Disease Type 1A
Not yet recruitingPeking University Third Hospital1002026-12-012026-10-26
Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in France
Genetic and Inflammatory Polyneuropathies
Not yet recruitingAssistance Publique - Hôpitaux de Paris10002026-11-012026-10-01
Genotype/Phenotype Correlation of MORC2 Mutations
Skin biopsy, Blood sample - Charcot Marie Tooth Disease, DIFGAN
RecruitingHospices Civils de Lyon452026-06-162026-06-18
Physical Activity Level at Home in CMT1A Patients: Wearable Sensor Assessment
Charcot-Marie-Tooth Disease, Type IA, Peripheral Neuropathy Hereditary
Not yet recruitingUniversity Hospital, Limoges602026-06-012026-05-22
Ultrasound-Guided Nerve Hydrodissection for Diabetic Lower Limb Entrapment Neuropathy
Ultrasound-guided nerve hydrodissection treatment, Sham treatment - Diabetic Peripheral Neuropathy, Entrapment Neuropathy
Not applicableRecruitingChongqing Medical University2662026-05-202026-06-17
Kinesio Taping for Pain, Median Nerve Morphology, and Quality of Life in Patients With Carpal Tunnel Syndrome
Kinesio Taping, Nerve and Tendon Gliding Exercises - Carpal Tunnel Syndrome, Median Nerve Compression
Not applicableCompletedIstanbul Gelisim University402026-05-102026-08-03
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Whole-body Electrical Muscle Stimulation Exercise - Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Not applicableRecruitingUniversity of Missouri-Columbia502026-03-102026-03-17
Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers
Gait analysis via video capture - Spinal Muscular Atrophy (SMA), Charcot-Marie-Tooth
Not applicableRecruitingInstitut de Myologie, France302026-03-032026-05-19
The Effectiveness of Low-Level Laser Therapy in the Treatment of Meralgia Paresthetica
Transcutaneous Electrical Nerve Stimulation (TENS), Low-Level Laser Therapy - Meralgia Paresthetica, Lateral Femoral Cutaneous Nerve Entrapment
Not applicableCompletedIstanbul Training and Research Hospital362026-03-022026-07-08
Walking Function Outcomes Following Surgical Correction With Rehabilitation Versus Physical Therapy Alone in Charcot-Marie-Tooth Disease: A Bidirectional Cohort Study
Functional Surgery plus Rehabilitation, Physical Exercise - Charcot Marie Tooth Disease (CMT), Pes Cavovarus
Not yet recruitingPeking University Third Hospital2002026-02-112026-02-25
High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes
High-Intensity Laser Therapy (HILT), Sham High-Intensity Laser Therapy - Carpal Tunnel Syndrome
Not applicableRecruitingAnkara City Hospital Bilkent802025-11-022026-02-17
A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.
EDK060, dose A, EDK060, dose B, EDK060, dose C - Charcot-Marie-Tooth Disease, Type 1A
Phase 1RecruitingNovartis Pharmaceuticals282025-09-302026-07-29
Effects of Resistance Exercises in Hereditary Sensory-Motor Neuropathy (Charcot-Marie-Tooth Disease)
Progressive Resistance Exercise Training - Polyneuropathy, Charcot Marie Tooth Disease (CMT)
Not applicableRecruitingUniversidad de La Frontera222025-09-202025-09-23
CMT Gait, Mobility, Balance - AOFAS Grant
Ankle-foot Orthoses - Charcot Marie Tooth Disease (CMT)
Not applicableRecruitingBopha Chrea662025-08-142025-09-23
"Ultrasound Measures and Clinical Outcomes in Healthy Individuals, Mild and Moderate Carpal Tunnel Syndrome Patients"
ultrasound - Carpal Tunnel Syndrome (CTS), Median Nerve Entrapment
CompletedIstanbul University752025-07-252026-02-13
Topical Cannabidiol for Treating Carpal Tunnel Syndrome
Cannabidiol - Carpal Tunnel Syndrome
Phase 2Not yet recruitingUniversity of Virginia202025-07-012025-04-11
Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease
Quantitative neuromuscular MRI, Skin biopsy, Clinical scores - Charcot-Marie-Tooth Disease Type 1A
Not applicableActive not recruitingAssistance Publique Hopitaux De Marseille552025-06-242026-10-28
Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients
Quantitative neuromuscular MRI, Neuromuscular ultrasound - Charcot-Marie-Tooth Neuropathy Type 1A, Hereditary Transthyretin Amyloid Neuropathy
Not applicableRecruitingAssistance Publique Hopitaux De Marseille1202025-05-232026-10-29
Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient
VCA-894A - Charcot Marie Tooth Disease (CMT), Neuromuscular Diseases (NMD)
Phase 1 / Phase 2Active not recruitingVanda Pharmaceuticals12025-05-132026-08-19

Showing 20 of 112. Sign in to see all of them.

Narrower conditions

Neuromuscular Diseases (11)  ·  Carpal Tunnel Syndrome (10)  ·  Peripheral Nervous System Diseases (9)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (9)  ·  Hereditary Sensory and Motor Neuropathy (7)  ·  Median Neuropathy (6)  ·  Amyotrophic Lateral Sclerosis (5)  ·  Muscular Atrophy, Spinal (5)  ·  Muscular Dystrophy, Facioscapulohumeral (5)  ·  Muscular Dystrophies (4)  ·  Myotonic Dystrophy (4)  ·  Nerve Compression Syndromes (4)  ·  Polyneuropathies (4)  ·  Refsum Disease (4)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (112)  ·  Congenital Abnormalities (111)  ·  Heredodegenerative Disorders, Nervous System (111)  ·  Nervous System Malformations (111)  ·  Neurodegenerative Diseases (111)  ·  Genetic Diseases, Inborn (110)  ·  Nervous System Diseases (110)  ·  Polyneuropathies (108)  ·  Hereditary Sensory and Motor Neuropathy (105)  ·  Peripheral Nervous System Diseases (103)  ·  Neuromuscular Diseases (101)  ·  Pathological Conditions, Signs and Symptoms (30)  ·  Central Nervous System Diseases (17)  ·  Pathologic Processes (17)  ·  Immune System Diseases (16)

Interventions

Exercise (3)  ·  Ascorbic Acid (2)  ·  Hematologic Tests (2)  ·  Rehabilitation (2)  ·  Transcutaneous Electric Nerve Stimulation (2)  ·  Biotin (1)  ·  Blood Specimen Collection (1)  ·  Cannabidiol (1)  ·  Disease Vectors (1)  ·  Glucose (1)  ·  Long-Term Synaptic Depression (1)  ·  Low-Level Light Therapy (1)  ·  Mexiletine (1)  ·  Naltrexone (1)  ·  Radiofrequency Ablation (1)

Sponsors

University Medical Center Goettingen (5)  ·  Pharnext S.C.A. (4)  ·  University of Iowa (4)  ·  Ankara City Hospital Bilkent (3)  ·  Assistance Publique Hopitaux De Marseille (3)  ·  Centre Hospitalier Universitaire de Liege (3)  ·  Peking University Third Hospital (3)  ·  University Hospital, Clermont-Ferrand (3)  ·  Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA (2)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Centre Hospitalier Universitaire de Nice (2)  ·  Children's Hospital of Philadelphia (2)  ·  ENCell (2)  ·  Istanbul University - Cerrahpasa (2)  ·  Maxima Medical Center (2)

Countries

United States (40)  ·  France (22)  ·  United Kingdom (11)  ·  Italy (10)  ·  Canada (9)  ·  Turkey (Türkiye) (9)  ·  Belgium (7)  ·  Germany (7)  ·  Netherlands (5)  ·  Spain (5)  ·  Australia (4)  ·  Denmark (4)  ·  South Korea (4)  ·  China (3)  ·  Cyprus (2)

Top investigators

Michael E Shy, MD (4)  ·  Adeline Vanderver, MD (2)  ·  David Herrmann, MBBCh (2)  ·  Mark Roberts, MD (2)  ·  Rudi Roumen, MD, PhD (2)  ·  Shahram Attarian, MD (2)  ·  Teresa Sevilla, MD (2)  ·  Zarife Sahenk, MD., PhD. (2)  ·  Aftab Ahmed Mirza Baig, DPT,MSAPT (1)  ·  Allison Moore (1)  ·  Angelo E Schenone, MD (1)  ·  Berna Orhan, MD (1)

Results publications

PMID 25519680, PMID 37395948, PMID 10411196, PMID 11232233, PMID 11382253, PMID 12235608, PMID 12671856, PMID 12851579, PMID 14564276, PMID 15610704, PMID 15680560, PMID 1577335, PMID 17210425, PMID 17986401, PMID 18312102, PMID 18455840, PMID 18843618, PMID 19084178, PMID 19181226, PMID 19457636, PMID 19479509, PMID 19703733, PMID 19774309, PMID 19782873, PMID 19909499, PMID 20595866, PMID 20850975, PMID 21254193, PMID 21694556, PMID 22475878, PMID 23182641, PMID 23797954, PMID 23806957, PMID 24090983, PMID 25286435, PMID 25430934, PMID 25491744, PMID 25546691, PMID 26070802, PMID 26142079, PMID 26183690, PMID 26247043, PMID 27124017, PMID 27387831, PMID 27469410, PMID 27876086, PMID 28284873, PMID 28394089, PMID 28484650, PMID 28768847

NIH funding

U54NS065712 (4), 2015 (2), 2025 (1), R01HD113778 (1), U01NS106845 (1), U01TR001263 (1), U54NS064808 (1), U54NS115052 (1)